Q32 Bio (QTTB) Institutional Ownership → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free QTTB Stock Alerts $25.85 +0.26 (+1.02%) (As of 05/6/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for Q32 Bio (NASDAQ:QTTB)CurrentInstitutional OwnershipPercentage31.32%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$61.17MNumber ofInstitutional Sellers(last 12 months)0 Get QTTB Insider Trade Alerts Want to know when executives and insiders are buying or selling Q32 Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad InvestorPlaceWatch this FREE trading tutorial while it’s still availableOn Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.Click here for details. Q32 Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/6/2024Atlas Venture Life Science Advisors LLC2,092,106$35.65M3.3%N/A64.254% 5/3/2024 Carlyle Group Inc.1,102,741$18.07M1.1%N/A33.826% 4/23/2024 BML Capital Management LLC24,894$424K0.3%N/A0.764% 4/22/2024 Vivo Capital LLC370,068$6.31M0.5%N/A11.366% (Data available from 1/1/2016 forward) QTTB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of QTTB shares? During the previous two years, the following institutional investors and hedge funds held shares of Q32 Bio shares: Atlas Venture Life Science Advisors LLC ($35.65M), Carlyle Group Inc. ($18.07M), and Vivo Capital LLC ($6.31M), BML Capital Management LLC ($424K).Learn more on QTTB's institutional investors. What percentage of Q32 Bio stock is owned by institutional investors? 31.32% of Q32 Bio stock is owned by institutional investors. Learn more on QTTB's institutional investor holdings. Which institutional investors have been buying Q32 Bio stock? The following institutional investors have purchased Q32 Bio stock in the last 24 months: Atlas Venture Life Science Advisors LLC ($2.09M), Carlyle Group Inc. ($1.10M), Vivo Capital LLC ($370.07K), and BML Capital Management LLC ($24.89K). How much institutional buying is happening at Q32 Bio? Institutional investors have bought a total of 3,589,809 shares in the last 24 months. This purchase volume represents approximately $61.17M in transactions. Related Companies: Abeona Therapeutics Institutional Ownership SELLAS Life Sciences Group Institutional Ownership PMV Pharmaceuticals Institutional Ownership Milestone Pharmaceuticals Institutional Ownership Reviva Pharmaceuticals Institutional Ownership Hookipa Pharma Institutional Ownership Allakos Institutional Ownership Aclaris Therapeutics Institutional Ownership Eton Pharmaceuticals Institutional Ownership Assertio Institutional Ownership This page (NASDAQ:QTTB) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Q32 Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.